Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |